Research ArticleNuclear Oncology
Two-Step Immunoscintigraphy for Non-Small-Cell Lung Cancer Staging Using a Bispecific Anti-CEA/Anti-Indium-DTPA Antibody and an Indium-111-Labeled DTPA Dimer
J.Ph. Vuillez, D. Moro, P.Y. Brichon, E. Rouvier, E. Brambilla, J. Barbet, P. Peltier, P. Meyer, R. Sarrazin and Ch. Brambilla
Journal of Nuclear Medicine April 1997, 38 (4) 507-511;
J.Ph. Vuillez
D. Moro
P.Y. Brichon
E. Rouvier
E. Brambilla
J. Barbet
P. Peltier
P. Meyer
R. Sarrazin
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Two-Step Immunoscintigraphy for Non-Small-Cell Lung Cancer Staging Using a Bispecific Anti-CEA/Anti-Indium-DTPA Antibody and an Indium-111-Labeled DTPA Dimer
J.Ph. Vuillez, D. Moro, P.Y. Brichon, E. Rouvier, E. Brambilla, J. Barbet, P. Peltier, P. Meyer, R. Sarrazin, Ch. Brambilla
Journal of Nuclear Medicine Apr 1997, 38 (4) 507-511;
Two-Step Immunoscintigraphy for Non-Small-Cell Lung Cancer Staging Using a Bispecific Anti-CEA/Anti-Indium-DTPA Antibody and an Indium-111-Labeled DTPA Dimer
J.Ph. Vuillez, D. Moro, P.Y. Brichon, E. Rouvier, E. Brambilla, J. Barbet, P. Peltier, P. Meyer, R. Sarrazin, Ch. Brambilla
Journal of Nuclear Medicine Apr 1997, 38 (4) 507-511;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Pretargeting: A Path Forward for Radioimmunotherapy
- Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
- Improved Targeting of Pancreatic Cancer: Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy
- Pretargeted Radioimmunotherapy of Cancer: Progress Step by Step
- Immunoscintigraphy with Positron Emission Tomography: Gallium-68 Chelate Imaging of Breast Cancer Pretargeted with Bispecific Anti-MUC1/Anti-Ga Chelate Antibodies
- Successful Surgical Removal of Occult Metastases of Medullary Thyroid Carcinoma Recurrences with the Help of Immunoscintigraphy and Radioimmunoguided Surgery